NEW YORK, December 17, 2021 /PRNewswire/ — The market for immunoassays is fragmented, and the degree of fragmentation will decrease over the forecast period. Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Tecan Group Ltd. and Thermo Fisher Scientific Inc. are among the main market participants. The market for immunoassays will grow through: USD 12.55 billion from 2021 to 2026. However, growth momentum is likely to slow by a CAGR of 7.40% during the forecast period, according to Technavio.
To know the exact growth variance and YOY growth rate – Request a free sample report.
Immunoassay Market 2022-2026: Scope
Technavio provides a detailed picture of the market through the study, synthesis and summation of data from multiple sources. Our immunoassay market report covers the following areas:
Immunoassay market 2022-2026: drivers and challenges
Predictive and preventive medicine for early diagnosis and treatment, and the advancement in laboratory automation platforms offers enormous growth opportunities. however, the limited number of skilled professionals will challenge the growth of market participants. The holistic analysis of the drivers and challenges will help in deriving end goals and refining marketing strategies to gain a competitive advantage. To take full advantage of the opportunities, market vendors need to focus more on the growth prospects in the high-growth segments, while maintaining their positions in the slow-growing segments.
Immunoassay Market 2022-2026: Segmentation
The market research report provides detailed information about the competitive intelligence, marketing gaps, segmentation and regional opportunities for suppliers, which will help in making efficient business plans.
Immunoassay Market 2022-2026: Key Regions and Revenue Generating Segment
44% of the market’s growth will come from North America during the forecast period. The US is the leading market for immunoassay in North America. However, the market growth in this region will be slower than the market growth in the European and Asian regions. The rapidly growing elderly population and high prevalence of chronic and infectious diseases will facilitate the growth of the immunoassay market in the coming years North America during the forecast period.
The immunoassay market share of growth by the segment reagents and kits will be important for monetization. The Technavio report provides an accurate forecast of the contribution of all segments to the growth of the immunoassay market size and actionable market insights for each segment.
Immunoassay Market 2022-2026: Key Highlights
CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will support Immunoassay market growth over the next five years
– Estimation of the Immunoassay market size and its contribution to the parent market
Predictions on emerging trends and changes in consumer behavior
The growth of the immunoassay market
Analysis of the competitive landscape of the market and detailed information about suppliers
Comprehensive details of factors that will challenge the growth of immunoassay market vendors:
Subscribe to our “Lite Plan” billed annually on USD 3000 which allows you to download 3 reports/year and view 3 reports/month.
Cancer Immunotherapy Market –Cancer immunotherapy market share is expected to increase by USD 74.45 billion from 2021 to 2026, and the market growth momentum is set to accelerate at a CAGR of 14.67%. Download a free sample now!
Smoking cessation and nicotine addiction market – The market share of smoking cessation and nicotine addiction is expected to increase by $18.01 billion from 2020 to 2025, and the market growth momentum is set to accelerate at a CAGR of 11.59%. Download a free sample now!
Market size of the immunoassay
Growth momentum & CAGR
Slow down at a CAGR of 7.40%
Market growth 2022-2026
USD 12.55 billion
YoY Growth (%)
North America, Europe, Asia and ROW
Performing Market Contribution
North America at 44%
Main consumer countries
US, UK, China, Germany and France
Leading Companies, Competitive Strategies, Consumer Engagement Range
Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Tecan Group Ltd. and Thermo Fisher Scientific Inc.
Parent market analysis, Inductors and obstacles to market growth, Analysis of high-growth and slow-growing segments, COVID-19 impact and future consumer dynamics, analysis of market conditions for the forecast period,
If our report doesn’t provide the data you’re looking for, contact our analysts and have segments tailored.
Technavio is a leading global technology research and consultancy company. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With more than 500 specialist analysts, Technavio’s report library consists of more than 17,000 reports and 800 technologies across 50 countries. Their customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s extensive coverage, extensive research and actionable market insights to identify opportunities in existing and potential markets and assess their competitive position within changing market scenarios.
View original content to download multimedia: https://www.prnewswire.com/news-releases/immunoassay-market-to-grow-by-usd-12-55-bn-predictive-and-preventive-medicine-for- early-diagnosis-treatment-to-growth-17000-technavio-reports-301447165.html